SCHEMBL7345938

SCHEMBL7345938

Nc1nc2c([nH]1)c(=O)[nH]c(=O)n2CC1CC1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 1/20 0.66
PDE4A P27815 1/20 0.66
PDE4B Q07343 1/20 0.66
PDE4C Q08493 1/20 0.66
PDE4D Q08499 1/20 0.66
MEN1 O00255 1/20 0.50
ALDH1A1 P00352 1/20 0.50
CYP3A4 P08684 1/20 0.50
KMT2A Q03164 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ADORA1 P30542 1/20 0.44
TLR7 Q9NYK1 10/20 0.43
TLR8 Q9NR97 7/20 0.43
ADORA2A P29274 1/20 0.43
ADORA2B P29275 1/20 0.43
PNP P00491 2/20 0.40
MTOR P42345 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3188553 0.82 PDE5A (0.45) PDE5APDE4APDE4BPDE4CPDE4D
Cipamfylline SCHEMBL26990 0.79 PDE4A (1.00) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL7616696 0.79 PDE5A (0.42) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL3179033 0.77 ADORA1 (0.45) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL3177231 0.77 ADORA1 (0.48) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL7624397 0.77 ADORA1 (0.49) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL8991683 0.77 PDE4A (0.64) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL7345942 0.77 PDE5A (0.62) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL11016276 0.76 PDE5A (0.54) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL3177612 0.76 ADORA2A (0.49) PDE5APDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1030666-A4 NOVEL USE OF COMPOUNDS FOR ANTI-PRURITIC ACTIVITY SMITHKLINE BEECHAM (US) 2002-10-16 EP disclosed
EP-1030666-A1 NOVEL USE OF COMPOUNDS FOR ANTI-PRURITIC ACTIVITY Smithkline Beecham (US) 2000-08-30 EP disclosed
WO-1999020280-A1 NOVEL USE OF COMPOUNDS FOR ANTI-PRURITIC ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 1999-04-29 WO disclosed
EP-0558659-A4 TNF INHIBITORS 1993-10-20 EP disclosed
EP-0558659-A1 TNF INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1993-09-08 EP disclosed
WO-1992009203-A1 TNF INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1992-06-11 WO disclosed